Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2000
10/04/2000CN1056988C Traditional Chinese medicine for curing arthralgia-syndrome
10/04/2000CN1056980C Compound balson pear capsules for curing diabetes, and prepn. method thereof
10/04/2000CN1056974C Method for preparing drug material suitable for micronisation
10/04/2000CN1056973C Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/03/2000US6127430 Cleaning agents, solvents, and delivery systems; may also contain a fluorinated surfactant or a mixture of such and may also contain a cosurfactant and/or cosolvent
10/03/2000US6127429 Ultrasonic atomization for production of aerosols
10/03/2000US6127428 Reducing the effects of right to left circulatory shunt comprising the steps of introducing into a blood vessel a therapeutically-effective amount of stabilized microbubbles, e.g. oxygen in a carrier such as a perfluorocarbon
10/03/2000US6127425 A solution of tamoxifen citrate and a mixture of ethanol, a glycol, e.g. propylene glycol, glycerol, and water; high concentration to be the equivalent of solid dosage of tasmoxifen; crystallization inhibition; complexes-free
10/03/2000US6127363 Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/03/2000US6127334 Mixing acidic solution of insulin, zinc, and a sub-isophanic amount of protamine with an alkaline solution of a physiological buffer; where one solution contains a phenolic compound, to form suspension, leaving to form phases
10/03/2000US6126971 Stable oral CI-981 formulation and process for preparing same
10/03/2000US6126970 Coating of polyvinyl chloride or terpolymer of vinyl chloride, vinyl acetate and vinyl alcohol with pores for water soluble or gastrointestinal fluids
10/03/2000US6126969 Immediate release/sustained release compressed tablets
10/03/2000US6126968 Stable compositions containing N-propargyl-1-aminoindan
10/03/2000US6126967 Sustained release agents for pain relief
10/03/2000US6126966 Liposomes containing a cisplatin compound
10/03/2000US6126965 Cationic liposomes of dimethyldioctadecylammonium bromide, phosphatidylcholine and cholesterol with encapsulation
10/03/2000US6126963 Bags for transdermal drug therapy
10/03/2000US6126962 Crystalline powdery saccharide, its preparation and uses
10/03/2000US6126959 Pharmaceutical composition for treating dysmenorrhea and premature labor
10/03/2000US6126958 Representative drugs include contraceptive agents and other steroidal substances for use in hormone replacement therapy.
10/03/2000US6126957 Ticrynafen or indacrinone in an amount effective to lower interocular pressure
10/03/2000US6126956 Subcutaneous implant
10/03/2000US6126951 Silicone-free carbon based replacements for the volatile cyclomethicones.
10/03/2000US6126948 Stable oil-in-water emulsion, process for its manufacture and its use in the cosmetic and dermatological fields
10/03/2000US6126946 Hepatocyte-selective oil-in-water emulsion
10/03/2000US6126942 Herbal compositions for hepatic disorders
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000US6126936 Microcapsules and composite microreactors for immunoisolation of cells
10/03/2000US6126930 Reducing trigeminal stimulation from an atomized alcohol
10/03/2000US6126921 Hair treatment formulations containing a water-insoluble polymer having a glass transition temperature of -20° C. to 70° C.
10/03/2000US6126920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition
10/03/2000US6126919 Metered dose inhaler for sustained release
10/03/2000US6126767 Method of manufacturing caplets with a gelatin cover
10/03/2000CA2190180C Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders
10/03/2000CA2172664C Interferon solution
10/03/2000CA2117046C Liposomal antibiotic formulation
10/03/2000CA2115444C Preparation for intratracheobronchial administration
10/03/2000CA2115065C Ultrafine particle powder for inhalation and method for production thereof
10/03/2000CA2000336C Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
10/01/2000CA2302854A1 Nail polish comprising a polymer water dispersion
09/2000
09/30/2000CA2303570A1 Stable foam compositions
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056726A1 Improved aqueous solubility pharmaceutical formulations
09/28/2000WO2000056439A1 Method for the preparation of particles
09/28/2000WO2000056366A1 Gel-microemulsion formulations
09/28/2000WO2000056365A1 Use of trehalose for stabilising a liquid vaccine
09/28/2000WO2000056364A1 Propofol formulation containing tris
09/28/2000WO2000056362A2 Polycationic carbohydrates as immunostimulants in vaccines
09/28/2000WO2000056361A2 Vaccine composition
09/28/2000WO2000056356A2 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
09/28/2000WO2000056353A2 A uro-genital condition treatment system
09/28/2000WO2000056346A1 Stable oil-in-glycerin emulsion
09/28/2000WO2000056344A1 Artificial saliva
09/28/2000WO2000056340A1 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
09/28/2000WO2000056339A1 Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
09/28/2000WO2000056338A1 Quinazoline formulations and therapeutic use thereof
09/28/2000WO2000056336A2 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
09/28/2000WO2000056328A1 Increasing cerebral bioavailability of drugs
09/28/2000WO2000056301A2 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
09/28/2000WO2000056297A2 Pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth
09/28/2000WO2000056296A2 Compositions for improving fertility
09/28/2000WO2000056291A1 Pharmaceutical solubilized in aerosol propellant
09/28/2000WO2000056290A1 Transdermal therapy system and method for producing the same
09/28/2000WO2000056289A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
09/28/2000WO2000056288A1 Nanoparticles, complexes with polynucleotides and their use
09/28/2000WO2000056287A1 Tablets and process for producing the same
09/28/2000WO2000056286A1 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
09/28/2000WO2000056282A1 Particle based vaccine composition
09/28/2000WO2000056281A1 Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained
09/28/2000WO2000056280A1 Non-stinging coating composition
09/28/2000WO2000056279A1 Resorcinol composition
09/28/2000WO2000056266A2 Taste masking coating compositions
09/28/2000WO2000056263A1 Suppository package and production method therefor
09/28/2000WO2000056251A1 Cell-culture and polymer constructs
09/28/2000WO2000045878A3 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor
09/28/2000WO2000042942A3 Buccal drug delivery system for use in male contraception
09/28/2000WO2000041740A3 Particles for oral delivery of peptides and proteins
09/28/2000WO2000041481A3 Medicament forms having controlled release and containing active substances which easily dissolve in water
09/28/2000WO2000040205A3 Sustained release formulation with reduced moisture sensitivity
09/28/2000WO2000033822A9 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
09/28/2000WO2000023592A9 Minimal promoters and uses thereof
09/28/2000WO2000009085A3 Oral formulation containing cyclosporin
09/28/2000WO2000003741A3 Methods for reducing intraocular pressure using a3-adenosine antagonists
09/28/2000DE19913732A1 Nikotin-TTS mit einem Zusatz von Monoterpenketonen Nicotine TTS with an addition of monoterpene ketones
09/28/2000DE19913731A1 Medizinische Zubereitung, enthaltend als Wirkstoff zumindest einen Anteil von Acetylsalicylsäure Medical preparation comprising as active ingredient at least a portion of acetylsalicylic acid
09/28/2000DE19913692A1 Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen Mechanically stable pharmaceutical dosage forms containing liquid or semisolid surface-active substances
09/28/2000DE19913640A1 Pharmaceutical composition comprising drug, e.g. anticancer agent, encapsulated in liposomes, containing polymer-lipid conjugate as stabilizer to inhibit liposome aggregation
09/28/2000DE19913606A1 Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen Powdered Solubilisationshilfsstoffe for solid pharmaceutical dosage forms
09/28/2000DE19913333A1 Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections
09/28/2000DE19912623A1 Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile A method for increasing the stability during storage and / or application of light-sensitive therapeutic systems or components thereof
09/28/2000DE19912477A1 Self-adhesive transdermal therapeutic system for e.g. drug or hormone delivery, comprises an active agent deposit and a connected matrix, including a paper substrate
09/28/2000CA2367266A1 Gel-microemulsion formulations
09/28/2000CA2367132A1 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
09/28/2000CA2367118A1 A uro-genital condition treatment system
09/28/2000CA2367093A1 Propofol formulation containing tris
09/28/2000CA2367040A1 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
09/28/2000CA2367015A1 Methods of treating tardive dyskinesia and other movement disorders
1 ... 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 ... 2991